Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Surveys02:16

Surveys

17.2K
Often, psychologists develop surveys as a means of gathering data. Surveys are lists of questions to be answered by research participants, and can be delivered as paper-and-pencil questionnaires, administered electronically, or conducted verbally. Generally, the survey itself can be completed in a short time, and the ease of administering a survey makes it easy to collect data from a large number of people.
17.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expression of EGFRvIII and its co‑expression with wild‑type EGFR, or putative cancer stem cell biomarkers CD44 or EpCAM are associated with poorer prognosis in patients with hepatocellular carcinoma.

Oncology reports·2024
Same author

Releasing the restraints of Vγ9Vδ2 T-cells in cancer immunotherapy.

Frontiers in immunology·2023
Same author

Editorial: Immunotherapy for Prostate Cancer - turning the immunological desert into an oasis of hope.

Frontiers in oncology·2022
Same author

Mycobacterial immunotherapy for prostate cancer: where can we go from here?

Nature reviews. Urology·2020
Same author

Report of Objective Clinical Responses of Cancer Patients to Pharmaceutical-grade Synthetic Cannabidiol.

Anticancer research·2018
Same author

Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same journal

Anti-PD-(L)1 plus chemotherapy in advanced PD-L1-negative nonsquamous non-small cell lung cancer: a systematic review and meta-analysis.

Immunotherapy·2026
Same journal

Anti-TIGIT therapies in digestive cancers: from immune evasion to precision immunotherapy.

Immunotherapy·2026
Same journal

CAR cellular therapies for acute myeloid leukemia: current landscape and future directions.

Immunotherapy·2026
Same journal

Recent advances in bispecific natural killer cell engagers for cancer immunotherapy.

Immunotherapy·2026
Same journal

Exploring global research trends in sublingual immunotherapy of allergic rhinitis: a comprehensive bibliometric analysis.

Immunotherapy·2026
Same journal

Autoimmune encephalitis and axonal polyradiculoneuropathy following therapy with adalimumab and secukinumab: a case report and literature review.

Immunotherapy·2026
See all related articles

Related Experiment Video

Updated: Mar 9, 2026

Microbial Communities in Nature and Laboratory - Interview
29:13

Microbial Communities in Nature and Laboratory - Interview

Published on: May 28, 2007

6.9K

Interview with Professor Angus Dalgleish.

Angus Dalgleish1

  • 1Cancer Vaccine Institute (now known as the Institute for Cancer Vaccines and Immunotherapy), St George's University of London, London, UK.

Immunotherapy
|December 21, 2016
PubMed
Summary
This summary is machine-generated.

Professor Angus Dalgleish is a leading figure in oncology, heading cancer research at St. George's University of London and the Institute for Cancer Vaccines and Immunotherapy.

More Related Videos

Biology of Microbial Communities - Interview
14:42

Biology of Microbial Communities - Interview

Published on: May 28, 2007

9.1K
Interview: Protein Folding and Studies of Neurodegenerative Diseases
19:50

Interview: Protein Folding and Studies of Neurodegenerative Diseases

Published on: July 16, 2008

13.2K

Related Experiment Videos

Last Updated: Mar 9, 2026

Microbial Communities in Nature and Laboratory - Interview
29:13

Microbial Communities in Nature and Laboratory - Interview

Published on: May 28, 2007

6.9K
Biology of Microbial Communities - Interview
14:42

Biology of Microbial Communities - Interview

Published on: May 28, 2007

9.1K
Interview: Protein Folding and Studies of Neurodegenerative Diseases
19:50

Interview: Protein Folding and Studies of Neurodegenerative Diseases

Published on: July 16, 2008

13.2K

Area of Science:

  • Oncology
  • Cancer Immunotherapy
  • Vaccine Development

Background:

  • Professor Angus Dalgleish holds significant academic and leadership positions.
  • He is the Foundation Professor of Oncology at St. George's University of London.
  • He also serves as the Principal of the Institute for Cancer Vaccines and Immunotherapy.

Discussion:

  • The abstract highlights Professor Dalgleish's dual role in academic oncology and specialized cancer research.
  • This positions him at the forefront of advancing cancer treatments through immunotherapy and vaccine strategies.
  • His leadership suggests a focus on translational research and clinical application.

Key Insights:

  • Establishes Professor Dalgleish's expertise in oncology.
  • Underscores his leadership in cancer vaccine and immunotherapy research.
  • Indicates a strong connection between academic research and a dedicated institute.

Outlook:

  • Future research may focus on novel cancer vaccines and immunotherapies.
  • Collaborations between St. George's University and the Institute are likely.
  • Professor Dalgleish's work is poised to impact cancer treatment paradigms.